Predicting Which Bladder Cancer Patients Will Respond to Immunotherapy
0 Views
administrator
07/08/23
Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients with bladder cancer will respond to immunotherapy. The discovery, from a new study published in Nature Communications, could improve the survival of bladder cancer patients.
-
Category
Show more
Facebook Comments
No comments found